His major contributions to the field include refining the techniques of extrapleural pneumonectomy (EPP), developing methods to perform intraoperative heated chemotherapy, and creating clinical trials to establish working intraoperative chemotherapies. Dr. Sugarbaker's later research focused on improving drugs for therapy of malignant pleural mesothelioma.